Cargando…
Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
Our increasing understanding of the molecular biological characteristics of cancer and of cancer genomics is facilitating the development of immunotherapy and molecular targeted drugs for gastric cancer. After the approval of immune checkpoint inhibitors (ICIs) for melanoma in 2010, many different c...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Science Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061264/ https://www.ncbi.nlm.nih.gov/pubmed/37009054 http://dx.doi.org/10.2144/fsoa-2023-0002 |